Poland is a country in East-Central Europe with a population of about 38 million people.
After the Polish accession to the European Union in May 2004, the legal and administrative
framework to implement the EU Directive on Clinical Trials was enacted, just as in all other
Joining the EU has significantly contributed to a change in the perception of Poland as a suitable place to conduct clinical trials. Sponsors include Poland because they benefit from a regulatory environment which is standardized and predictable, whilst maintaining the advantage of lower cost and higher subject recruitment potential.